US 12,459,970 B2
Progesterone analogs and uses related thereto
David B. Guthrie, Avondale Estates, GA (US); Mark A. Lockwood, Johns Creek, GA (US); Dennis C. Liotta, Atlanta, GA (US); Michael G. Natchus, Alpharetta, GA (US); Donald G. Stein, Atlanta, GA (US); and Iqbal Sayeed, Atlanta, GA (US)
Assigned to Emory University, Atlanta, GA (US)
Filed by EMORY UNIVERSITY, Atlanta, GA (US)
Filed on Feb. 4, 2022, as Appl. No. 17/592,870.
Application 17/592,870 is a continuation of application No. 16/421,255, filed on May 23, 2019, granted, now 11,274,118.
Application 16/421,255 is a continuation of application No. 14/932,231, filed on Nov. 4, 2015, granted, now 10,336,787, issued on Jul. 2, 2019.
Application 14/932,231 is a continuation of application No. 13/767,106, filed on Feb. 14, 2013, abandoned.
Claims priority of provisional application 61/599,079, filed on Feb. 15, 2012.
Prior Publication US 2022/0235092 A1, Jul. 28, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/57 (2006.01); A61K 31/58 (2006.01); A61K 45/06 (2006.01); C07J 41/00 (2006.01); C07J 43/00 (2006.01)
CPC C07J 41/005 (2013.01) [A61K 31/57 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01); C07J 41/0016 (2013.01); C07J 43/003 (2013.01); Y02A 50/30 (2018.01)] 21 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.